Intra-athlete and inter-group comparisons: Running pace and step characteristics of elite athletes in the 400-m hurdles.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 16 08 2018
accepted: 19 03 2019
entrez: 29 3 2019
pubmed: 29 3 2019
medline: 28 11 2019
Statut: epublish

Résumé

The aim of this study was to investigate the running pace and step characteristics among various competitive-level 400-m hurdlers through inter-group and intra-athlete comparisons. We analysed spatiotemporal data involving the split time, mean step length (SL) and mean step frequency (SF) for 13 male world-class and 14 male national-level 400-m hurdlers. We analysed 16.5 ± 3.9 races for each world-class hurdler and 19.8 ± 6.0 races for each national-level hurdler (the total number of analysed runs was 491) using publicly available television and internet broadcasts. Inter-group comparisons showed that both first- and latter-halves split times of the world-class hurdlers were significantly shorter than those of the national-level hurdlers. In the latter-half phase, no significant differences of SL and SF were observed between the world-class and national level hurdlers. Intra-athlete comparisons showed that no athletes favoured only first-half phase in terms of running speed in short finish times. In contrast, finish times of all hurdlers were sensitive to running speed in the latter-half phase. In the latter half of the race, 18 of the 27 hurdlers were identified as being SF reliant during speed enhancements; running speed of the other 9 hurdlers were also sensitive to high SF. In conclusions, important findings regarding high performance in inter-group comparisons do not always corresponded with those in intra-athlete comparisons. All athletes and coaches should first prioritize maintaining high running speeds in the latter half of 400-m hurdles rather than in the first half of the race.

Identifiants

pubmed: 30921329
doi: 10.1371/journal.pone.0204185
pii: PONE-D-18-23101
pmc: PMC6438499
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0204185

Déclaration de conflit d'intérêts

This study was supported by the Yamaha Motor Foundation. This does not alter the adherence to PLoS ONE policies on sharing data and materials.

Références

J Strength Cond Res. 2016 Mar;30(3):635-42
pubmed: 26907837
Sports Biomech. 2011 Sep;10(3):219-33
pubmed: 21936290
J Appl Biomech. 2010 May;26(2):171-9
pubmed: 20498488
J Sports Sci. 2001 Feb;19(2):149-59
pubmed: 11217013
Sports Biomech. 2006 Jul;5(2):155-66
pubmed: 16939150
J Strength Cond Res. 2010 Sep;24(9):2309-15
pubmed: 20703164
Br J Sports Med. 1995 Jun;29(2):80-4
pubmed: 7551765
PLoS One. 2016 Oct 4;11(10):e0163712
pubmed: 27701443
Eur J Appl Physiol. 2011 Aug;111(8):1579-90
pubmed: 21190037
J Strength Cond Res. 2009 Mar;23(2):524-31
pubmed: 19209080
J Sports Sci. 2017 Feb;35(4):346-354
pubmed: 27008363
Can J Sport Sci. 1992 Jun;17(2):141-4
pubmed: 1324108
Med Sci Sports Exerc. 2004 Feb;36(2):261-71
pubmed: 14767249
J Biomech. 2016 Jun 14;49(9):1490-1497
pubmed: 27015963
J Sports Sci. 1992 Jun;10(3):217-28
pubmed: 1602525
J Hum Kinet. 2017 Dec 28;60:175-189
pubmed: 29339998
Int J Sports Med. 2015 Jun;36(6):494-7
pubmed: 25700099
Int J Sports Med. 2016 Feb;37(2):165-8
pubmed: 26509370
J Sports Sci. 2011 Jun;29(9):905-12
pubmed: 21547833
Med Sci Sports Exerc. 2011 Jun;43(6):1055-62
pubmed: 20980924
J Appl Physiol (1985). 2000 Nov;89(5):1991-9
pubmed: 11053354

Auteurs

Mitsuo Otsuka (M)

Faculty of Sport and Health Science, Ritsumeikan University, Kusatsu, Shiga, Japan.

Tadao Isaka (T)

Faculty of Sport and Health Science, Ritsumeikan University, Kusatsu, Shiga, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH